United States Drug Enforcement Administration

The DEA is grateful for the President’s leadership on this issue as we continue our fight to combat the nation’s opioid epidemic. This legislation is critical to DEA’s mission - to keep Americans safe by keeping these dangerous drugs off the streets. We look forward to working with our partners...

CINCINNATI – A federal grand jury has charged 36 individuals with crimes related to narcotics and money laundering conspiracies in an indictment that was unsealed today. Those charged include 22 local individuals. Law enforcement agents arrested all 36 defendants late last week and over the weekend. According to the indictment...

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...

WASHINGTON – Christopher T. Tersigni, Special Agent in Charge of the Special Operations Division of the U.S. Drug Enforcement Administration, and Geoffrey S. Berman, the U.S. Attorney for the Southern District of New York, today announced that Estonian residents Jevgeni Bokov, Viktor Litvintsuk, Amid Magerramov, Nikolai Niftalijev, and Vitali Voronjuk...

WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...

WASHINGTON - While in Cleveland, Ohio, Attorney General Jeff Sessions today announced the unsealing of a 43-count indictment in federal court in Cleveland, which charges two Chinese citizens with operating a conspiracy that manufactured and shipped deadly fentanyl analogues and 250 other drugs to at least 25 countries and 37...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...